VenatoRx Pharmaceuticals, Inc.

2:15 PM - 2:30 PM, Wednesday, June 5, 2019 ・ Theater 3
VenatoRx Pharmaceuticals is a private company focused on the discovery and development of novel anti-infectives to treat multi-drug-resistant (MDR) bacterial infections and hard-to-treat viral infections.
Ticker:
Not Provided.
Exchange:
Not Provided.
Company Type:
Company Website:
Company HQ State:
Pennsylvania
Company HQ Country:
United States
Year Founded:
2010
Main Therapeutic Focus:
Lead Product in Development:
cefepime/VNRX-5133
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
4
Speaker
photo
President and CEO
VenatoRx Pharmaceuticals